Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Magn Reson Imaging. 2012 Feb;30(2):261-70. doi: 10.1016/j.mri.2011.09.006. Epub 2011 Nov 12.
The aim of this study was to understand the neuropharmacological characteristics of levo-tetrahydropalmatine (l-THP), a recently found potential treatment for drug addiction, and discover its neural correlates and sites of action.
High-field pharmacological magnetic resonance imaging (phMRI) was used to detect activation induced by acute l-THP administration in the naïve rat brain at dose levels of 5, 10, 20 and 40 mg/kg.
Interestingly, the pharmacological profile of l-THP selectively binds to the receptors of the dopaminergic, serotonergic and noradrenergic systems. Using the phMRI method, it was demonstrated that l-THP selectively activated the key brain regions of the dopaminergic, serotonergic and noradrenergic systems in a dose-dependent manner.
Numerous studies suggest a critical role of monoamines in the behavioral, pharmacological and addictive properties of psychostimulants. It is suggested that l-THP holds great potential to be a therapeutic medication for drug addiction.
本研究旨在了解左旋延胡索乙素(l-THP)的神经药理学特性,左旋延胡索乙素是一种新发现的潜在药物成瘾治疗药物,并发现其神经相关和作用部位。
高场药理学磁共振成像(phMRI)用于检测在 5、10、20 和 40 mg/kg 剂量水平下急性 l-THP 给药在未处理大鼠脑中诱导的激活。
有趣的是,l-THP 的药理学特征选择性结合到多巴胺能、5-羟色胺能和去甲肾上腺素能系统的受体。使用 phMRI 方法,证明 l-THP 以剂量依赖性方式选择性激活多巴胺能、5-羟色胺能和去甲肾上腺素能系统的关键脑区。
大量研究表明单胺类物质在精神兴奋剂的行为、药理学和成瘾特性中起着关键作用。因此,l-THP 极有可能成为治疗药物成瘾的药物。